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Abstract  
Objective – To describe the successful management of a dog with acute respiratory distress 
syndrome secondary to inhalant toxin exposure. Case summary – An 8-year-old male neutered 
Greyhound was referred with severe respiratory distress 56 hours after exposure to an aerosol 
toxicant. The patient developed respiratory difficulties requiring vet- erinary attention within 12 
hours of initial exposure. Treatment at the referral hospital included mechanical ventilation and 
supportive care. The patient was discharged 5 days after admission to the referral hospital. New or 
unique information – This is the first report, to the authors’ knowledge, of canine acute respiratory 
distress syndrome secondary to inhalant toxin exposure not associated with smoke inhalation. The 
report summarizes the provided care and subsequent successful outcome.  
(J Vet Emerg Crit Care 2018; 00(0): 1–7) doi: 10.1111/vec.12754  
Keywords: acute lung injury, ARDS, canine, mechanical ventilation, pulmonary injury  
Abbreviations  
ARDS acute respiratory distress syndrome  
BAL bronchoalveolar lavage  
CT computed tomography  
PEEP positive end-expiratory pressure  
VetARDS veterinary acute lung injury and acute respi-ratory distress syndrome  
Introduction  
Acute lung injury and acute respiratory distress syn- drome (ARDS) share the same 
inflammatory related pathophysiology and are differentiated by the degree of 
hypoxemia.1 Precise definitions of the 2 syndromes exist in people,2 although acute lung 
injury is no longer part of the recommended terminology in human medicine.3 
Definitions for veterinary acute lung injury and acute respiratory distress syndrome 
(VetARDS) were created by the Dorothy Havemeyer working group and are de- scribed 
elsewhere.4  
Many risk factors have been documented for ARDS in people and these are assumed to 
be similar in dogs.4 Veterinary acute lung injury and acute respiratory dis- tress 
syndrome is a rare clinical entity with only sporadic reports in the veterinary literature 
of successful manage- ment in dogs5–7; however, inhalant toxins (including the 
compounds outlined in this report) other than smoke have not been documented as a 
cause for VetARDS.1 A previously published case series describes 2 dogs that developed 
chemical pneumonitis secondary to inhala- tion of a waterproofing spray containing 
hydrocarbons.8 Both dogs recovered with supportive care; however, nei- ther dog was 
definitively diagnosed with VetARDS due to a lack of arterial blood gas sampling.  
This report describes a case of canine VetARDS follow- ing exposure to an inhalant 
toxin, a commercial grout protector spray,a along with its management and suc- cessful 
outcome. The constituents of the spray are fluo- rinated carbon polymers, petroleum 
naphtha, heptane, butane, and propane (2-3%, 10–20%, 30–60%, 10–30%, and 10–30% by 
weight, respectively).  
Case Summary  
An 8-year-old, 28.5 kg male neutered Greyhound was referred to the Emergency Service 
of the Queen Mother Hospital for Animals of the Royal Veterinary College for acute 
onset of respiratory distress characterized by increased respiratory effort and 
tachypnea. The patient had been previously healthy other than a history of well 
controlled hypothyroidism.  
On the day of initial presentation to the primary vet- erinarian (12 hours from 
exposure), both the owners and the patient were exposed to an aerosolized grout 
protec- tion producta documented by the manufacturers to be an irritant, with strict 
recommendations to avoid inhala- tion of any fumes/vapors via adequate ventilation of 
enclosed spaces or the use of an appropriate breathing apparatus. Both owners 
developed self-limiting respi- ratory signs, with one requiring hospitalization within 24 
hours of exposure. The dog described in the cur- rent report was assessed by his 
primary care veteri- narian for acute onset of tachypnea with the remainder of the 
clinical examination being unremarkable. Serum biochemistry and survey thoracic 
radiographs were re- ported as unremarkable. Hematology revealed increased 
hematocrit, increased RBC concentration, and increased hemoglobin, all findings 
consistent with his breed.9 Oxy- genation was assessed once during hospitalization, 
with an oxygen saturation (SpO2 ) (36 hours post-exposure) re- ported as >95%. 
Supportive care was provided includ- ing meloxicam, intravenous fluid therapy, 
cefuroxime, and metoclopramide; no supplemental oxygen was pro- vided. Due to 
progressive respiratory deterioration, he was referred for further diagnostic evaluation 
and inten- sive care.  
On admission to the intensive care unit at the Queen Mother Hospital for Animals (56 
hours following expo- sure) the dog had markedly increased respiratory effort and 
orthopnea, with a respiratory rate of 130/min. Rec- tal temperature was normal (38.5°C 
[101.3°F]). No ab- normalities were noted with the cardiovascular system. Thoracic 
auscultation revealed increased bronchovesic- ular noises bilaterally, considered to be 
consistent with the patient’s degree of increased respiratory effort. No adventitious 
respiratory sounds were audible. The re- mainder of the physical examination was 
unremarkable.  
Bilateral nasal cannulae were placed and oxygen was administered at 50–100 
mL/kg/min. While receiving supplemental oxygen, an arterial blood sampleb was 
taken yielding severe hypoxemia (Table 1). Biochemistryc documented mildly increased 
creatine kinase (Table 2). Hematologyd documented mild lymphopenia with increased 
RBC concentration, hemoglobin, hematocrit, and mean corpuscular hemo- globin (Table 
2). An Angiostrongylus vasorum ELISAe was negative.  
Due to the severity of hypoxemia, and subjective con- cern for respiratory fatigue, the 
patient was anesthetized 5 hours after presentation using midazolam,f fentanyl,g and 
propofol,h and a sterile endotracheal tube was placed. Volume-controlled mechanical 
ventilationi with positive end expiratory pressure (PEEP) of 7.8 cm H2O, tidal volume of 
10.1 mL/kg, and FiO2 of 0.8 was initi- ated. General anesthesia was maintained using 
infusions of midazolam (0.17–0.25 mg/kg/hr), fentanyl (0.05- 0.2 �g/kg/min), and 
propofol (0.08-0.2 mg/kg/min) and the patient was instrumented with arterial, cen- tral 
venous, and urinary indwelling catheters. Patient monitoring consisted of continuous 
electrocardiography, capnography, pulse oximetry, and direct blood pressure 
monitoring.  
Computed tomographyj (CT) of the thorax was per- formed and revealed a marked 
increase in soft tissue attenuation in all lung lobes, with a peripheral rim of un- affected 
lung (Figure 1). A blind bronchoalveolar lavage (BAL) was performed and cytology was 
nondiagnostic due to low cellularity. There was no evidence of intra- or extracellular 
bacteria, and culture subsequently revealed no growth of microorganisms.  
Within 3 hours of starting mechanical ventilation oxy- genation markedly improved 
(Table 1). However, hyper- capnia and acidemia developed (Table 1). A point-of-care 
thoracic ultrasound examination revealed no evidence of pneumothorax or pleural 
effusion. Despite the degree of lung involvement on CT only minimal B lines (“lung 
rockets”) were noted10 and no evidence of left atrial en- largement was identified that 
would be suggestive of left sided heart failure. An ACTH stimulation test, and a 
Baermann fecal floatation exam excluded hypoadreno- corticism and Angiostrongylus 
vasorum, respectively.  
During the first 23 hours of ventilation, PaCO2 remained increased reaching a peak of 
108.2 mm Hg (Table 1) despite a respiratory rate of 28–37/min, and tidal volume of 7.9-
12.4 mL/kg. Over the fol- lowing 21 hours, tidal volume was increased further (12.6-
14.5 mL/kg) and PaCO2 decreased, remaining below 65 mm Hg, with subsequent 
improvement in acidemia.  
After 40 hours of mechanical ventilation, the patient’s respiratory secretions appeared 
progressively more vis- cous and purulent. A second blind BAL was performed and in-
clinic cytology revealed neutrophilic inflamma- tion with no observed intracellular 
bacteria. The pa- tient’s oxygenation remained acceptable on an FiO2 of 0.4 (Table 1), 
and it was deemed appropriate to attempt weaning the patient from the mechanical 
ventilation. A dose of hydrocortisonek (1 mg/kg IV) was adminis- tered prior to 
weaning to reduce the mild oropharyngeal swelling that had developed during 
mechanical venti- lation. Prior to disconnection from the ventilator, the PEEP was 
decreased over a 4-hour period. During the same period, the FiO2 was titrated down 
(from 0.4 to 0.3); propofol, midazolam, and fentanyl infusions were tapered and 
stopped completely upon ventilator discon- nection. For the final hour of ventilation, 
the mode was switched to synchronized intermittent mandatory ven- tilation with a 
low level of pressure support (starting at 6 cm H2 O and gradually decreasing to 2 cm 
H2 O during the hour) to assess if adequate respiratory mus- cle strength was present. 
Urine output during the entire period of mechanical ventilation remained low (0.35– 1.7 
mL/kg/hr), but with normal specific gravity (1.045), and the patient developed 
progressive mild pitting edema in all four limbs and face. The patient was ex- tubated 
within 1 hour after disconnection from the ventilator, having spent total of 44 hours on 
mechanical ventilation and 45 hours intubated. Following extuba- tion, the patient 
became agitated and was subsequently administered 2 doses of methadonel (0.1 mg/kg 
IV) and one dose of medetomidinem (1 g/kg IV).  
Following weaning, nasal oxygen was administered at 50 mL/kg/min using the 
previously placed bilat- eral nasal cannulae. Rectal temperature began to in- crease 
(reaching a maximum of 40.0°C [104°F]) within the 4-hour period following 
disconnection from the ventila- tor. At the same time as the increased rectal 
temperature, reference laboratory evaluation of the second blind BAL documented 
neutrophilic inflammation with rare intra- cellular cocci and rods. Empiric intravenous 
amoxicillin clavulanaten was initiated (20 mg/kg IV every 8 hours) 6 hours from 
obtaining the second BAL while await- ing the culture results. Rectal temperature 
returned to normal (38.9C [102°F]) within 24 hours following dis- connection from the 
ventilator. The patient remained hypoxemic when breathing room air until 30 hours af- 
ter disconnection, when normoxemia was documented (Table 1); oxygen 
supplementation was discontinued at this stage. When the dog began to eat, 
levothyroxine sodiumo was restarted. Several decubitus ulcers had de- veloped over 
bony prominences and 1 site on the dis- tal left radius began discharging purulent 
material. This material was sampled and submitted for culture, and topical therapy 
with 0.05% chlorhexidine was initiated. Eleven hours after disconnection from the 
ventilator, the patient was eating, drinking, and fully ambulatory; 78 hours after 
disconnection the patient was discharged.  
Following discharge, the patient received a 5 day course of oral amoxicillin clavulanatep 
(11.4 mg/kg orally every 12 h) for his suspected bacterial pneumonia, tramadolq (1.75 
mg/kg orally every 8 h) for mild joint pain following prolonged recumbency and 
levothyrox- ine sodiumo (28.1 g/kg orally every 12 hr). Following discharge culture 
results for the discharging decubitus ulcer were reported as Escherichia coli, Pseudomonas 
aerug- inosa, and Enterococcus faecium, all of which were resis- tant to amoxicillin 
clavulanate. At the time these results were available the ulcer had fully healed and the 
patient had finished his initial course of antimicrobial therapy. Culture results for the 
second BAL were also available and documented no growth of microorganisms. As the 
dog was reported to be doing well, no additional an- timicrobials were prescribed. No 
repeat thoracic imaging was performed at any stage due to the owners’ financial 
constraints.  
On discussion with the owners 8 months after dis- charge the dog was reported to be 
clinically normal, with no change to his quality of life or on his level of function. His 
owners reported full recovery to his predisease state occurred within 2 weeks of 
discharge from the hospital.  
Discussion  
This report describes the development of VetARDS fol- lowing exposure to an inhalant 
toxicant in the dog. Current guidelines4 define VetARDS as acute onset (<72 hr) of 
tachypnea and labored breathing at rest, in the presence of known risk factors, with 
evidence of inefficient gas exchange. Tachypnea was noted within 12 hours of exposure 
to the toxic vapor, with a PaO2/FiO2 ratio &200 upon admission to the referral hospital 
(56 hours from exposure). The guidelines also require evidence of pulmonary capillary 
leak in the absence of in- creased pulmonary capillary pressures; although the pa- tient 
was not assessed by a board-certified cardiologist, there was no prior history of cardiac 
disease and point- of-care ultrasound examination did not show evidence of left atrial 
enlargement. Other diseases that may have caused severe respiratory distress, such as 
preexisting pneumonia and Angiostrongylus vasorum infection, were excluded based on 
initial BAL, ELISA testing, and Baer- manns’, respectively. Infectious pneumonia as a 
cause for the patient’s VetARDS was deemed highly unlikely on the basis of 2 negative 
BAL cultures, along with atyp- ical CT findings. Fungal pneumonia was discounted as 
neither BAL cytology was suggestive of fungal disease, and the patient had never 
travelled outside the United Kingdom. Neurogenic and negative pressure pulmonary 
edema were also unlikely due to the lack of predispos- ing factors, such as seizures or 
upper airway obstruction, along with the atypical pattern of pulmonary pathol- ogy. A 
nonmandatory criterion for VetARDS is evidence of diffuse alveolar inflammation.4 The 
authors are un- able to fulfill this criterion as the initial BAL sample was hypocellular 
and may not have been a representative air- way sample; the second BAL sample, while 
neutrophilic, documented bacteria.  
Given that the patient’s clinical signs developed shortly after exposure to the toxic 
vapor and resolved without the use of targeted treatment (ie, initial antibi- otics or 
furosemide), along with the lack of evidence of other identifiable disease processes to 
explain the sud- den respiratory dysfunction, the authors believe that the toxic exposure 
resulted in VetARDS in this patient.  
The initial hypoxemia noted improved rapidly after instituting mechanical ventilation 
(Table 1). Based solely on the PaO2/FiO2 ratio used in the Berlin definitions,3 our patient 
would be classified as having ‘moderate” ARDS initially, improving to ‘mild’ ARDS 
following 3 hours of mechanical ventilation. The Berlin definition requires arterial 
sampling be performed with a PEEP of 5 cm H2O; it is known that changes in both 
ventilator settings and FiO2 affect the PaO2/FiO2 ratio in people.11–13 Current VetARDS 
criteria do not include any requirement for PEEP during arterial sampling.4  
Even with predefined PEEP levels, standardized ven- tilator settings have been shown 
to affect the strati- fication of ARDS patients in people.11 Similar to the case presented 
here, both patients outlined by Kelmer et al also experienced marked improvements in 
the PaO2/FiO2 ratio within the first 2 hours of invasive me- chanical ventilation.5 The 
authors therefore believe that the marked changes in the PaO2/FiO2 ratio prior to and 
after instituting mechanical ventilation, are likely due to the application of PEEP and 
positive pressure ven- tilation. Acute respiratory distress syndrome in people must 
develop within 7 days of the injury or insult, but it is not classified based on the 
duration of ARDS itself.3 While many cases of ARDS in people have a prolonged time 
course, depending on etiology, some patients have a short duration of ARDS.14 
Although the patient pre- sented in this case improved quickly, and required only 44 
hours of mechanical ventilation, according to the cur- rent veterinary definitions, the 
patient fulfilled all criteria for VetARDS. Other currently confirmed cases of canine 
VetARDS have required between 17.5 hours and 13 days of mechanical ventilation.5,7 In 
a case series of dogs with respiratory distress, 10 patients underwent mechanical 
ventilation with a range of 2–92 hours (median 18.5 hr); 5 of these dogs fulfilled the 
human definition for ARDS as defined at that time.15 It seems logical to conclude that 
the underlying etiology and pathophysiology, along with the variable host response to 
tissue injury, may ex- plain the difference in duration of VetARDS cases re- ported thus 
far.  
The exact etiology of ARDS development following nonthermal inhalation injury varies 
depending on the toxin, not all constituents of the product described in this report have 
been thoroughly investigated as to their mechanism of pulmonary damage. Pulmonary 
injury following exposure to waterproofing grout sealers has been documented in 
people.16 A case report exists of a human developing ARDS after inhalation of vapors 
from heating fluorinated carbon polymers. The patient exhibited the same relative 
sparing of peripheral lung parenchyma on CT, required invasive mechanical venti- 
lation and was discharged 8 days after toxic exposure.14 The product inhaled by our 
patient contained fluorinated carbon polymers at 2–3% by weight. The mechanism of 
pulmonary injury from fluorinated carbon polymers is unknown, but may be due to 
surfactant disruption and subsequent alveolar collapse or type II pneumocyte 
injury.16,17 Another component of the product described is naphtha (petroleum) at 10–
20% by weight; naphtha vapor is known to be directly irritant to the respiratory and 
mucous membrane epithelium18 and may account for some degree of the oropharyngeal 
swelling noted prior to extubation. Prolonged orotracheal intubation likely accounts for 
the majority of the oropharyngeal swelling, given that it was not documented initially 
but appeared toward the end of mechanical ventilation. Fi- nally, the hydrocarbons 
contained within the product described in this report (heptane, butane, and propane; 
30–60%, 10–30%, and 10–30% by weight, respectively) have been reported to cause 
ARDS when inhaled in peo- ple, due to loss of surfactant and subsequent alveolar 
collapse.19 Hydrocarbons, as a group, are known to be directly irritant to the pulmonary 
tract, reducing surfac- tant levels, promoting pulmonary inflammation, bron- 
chospasm, pulmonary edema, and necrosis20,21; the net effects of these is reduced 
pulmonary compliance, hy- poxemia, and in some cases ARDS.21 The case presented in 
this report bears numerous similarities to previously reported chemical pneumonitis in 
2 dogs following hy- drocarbon inhalation8 with respect to the temporal re- lationship of 
toxic exposure, clinical deterioration over the first 24–72 hours, and subsequent 
complete recov- ery. Pneumonitis is likely part of the same spectrum of disease as 
ARDS1 and the dogs reported previously by Young et al may have had VetARDS. 
However, without a more thorough diagnostic workup (including blood gas analysis) 
the dogs do not meet the current definition.4 Neither of those dogs required mechanical 
ventilation and both recovered following supportive treatment with supplemental 
oxygen, bronchodilators, intravenous flu- ids, and either steroids or antimicrobials (1 
dog each respectively). The dog presented in this report was me- chanically ventilated 
allowing thorough diagnostic eval- uation, including bronchoalveolar lavage and 
arterial sampling, to be performed with reduced risk to the patient.  
Although this patient ultimately survived to dis- charge, several complications were 
encountered during the treatment period. Marked hypercapnia and acidemia that were 
responsive only to marked elevations in tidal volume occurred, with administration of 
tidal volumes higher than desired for a lung protective ventilation strategy. The use of 
lower tidal volumes in people with ARDS has resulted in improved survival rates;22 
how- ever, in this patient lower tidal volumes resulted in marked hypercapnia, reduced 
arterial oxygen tension, and severe respiratory acidosis (Table 1) despite in- creases in 
ventilator set respiratory rate until tidal vol- umes of 12.6–14.5 mL/kg were used. The 
commonly cited normal canine tidal volume is 10–15 mL/kg;23 hu- man athletes have 
higher tidal volumes than the nor- mal population24 and given the highly athletic nature 
of the Greyhound breed, it is reasonable to assume similar physiologic adaptations may 
exist. The authors feel that a lung protective ventilation strategy extrapo- lated from 
human medicine guidelines, with tidal vol- umes of 6–8 mL/kg,22 may not be directly 
applicable to all veterinary patients (eg, due to differences in chest conformation, 
internal thoracic volume, and respiratory system compliance between species and 
breeds) and fur- ther work could focus on the optimum ventilator settings in VetARDS 
patients. Low volume tidal ventilation (less than 10-15 mL/kg) has been proven to 
cause incremen- tal decreases in pH, increased PaCO2, and decreased lung compliance, 
but was well tolerated in a popula- tion of healthy dogs.25 The authors stipulated that 
the effects of low tidal volume ventilation in patients with VetARDS required further 
investigation. In this specific case, permissive hypercapnia was initially adopted but 
later abandoned due to persistent acidosis. Permissive hypercapnia is a cornerstone of 
lung protective ventilator strategies. In tolerating increased PaCO2 levels, the aim is to 
avoid damage induced by increased lung stretching.26 In one prospective study into 
permissive hypercapnia in people, the mean PaCO2 documented was 67 mm Hg, with 
an associated decrease in arterial pH (mean 7.23).27 It is not currently known if the 
beneficial effects of per- missive hypercapnia are due to the elevated carbon diox- ide 
itself or the acidosis, and buffering of the acidosis is controversial.2  
Conclusions  
Inhalant toxin exposure, other than smoke, has not previ- ously been reported as a 
cause of VetARDS. The temporal relationship, lack of any other defined risk factors, and 
concurrent respiratory issues experienced by the own- ers in contact with the same 
substance make it the most likely cause for VetARDS in this dog. Successful recov- ery 
was documented in this case following 44 hours of mechanical ventilation despite 
several complicating factors.  
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Tables and Figures 
 
  
Footnotes  
a  Nicobond grout protector aerosol retail 500 mL (N2540758), N&C Building Products Ltd., Romford, UK.   
b  Stat Profile pHOx Ultra, Nova Biomedical Corporation, MA.   
c  ILab600 Chemistry Analyzer, Instrumentation Laboratory, MA.   
d  Advia 2120i Haematology System, Siemens Healthcare Ltd., Camberley,  UK.   
e  Idexx Angio Detect, Idexx Europe B.V., Hoofddorp, the Netherlands.   
f  Midazolam hydrochloride, Roche Products Ltd., Welwyn Garden City,  UK.   
g  Fentanyl citrate, Eurovet Animal Health B.V., Bladel, The Netherlands.   
h  Propofol, Norbrook Laboratories Ltd., Newry, UK.   
i  Nellcor Puritan Bennett 840 Ventilator System, Puritan-Bennett Corporate,  Pleasanton, CA.   
j  16-slice MDCT scanner MX 8000 IDT, Philips Medical Systems, Cleveland,  OH.   
k  Hydrocortisone sodium succinate, Pfizer Ltd., Kent, UK.   
l Methadone hydrochloride, Le Vet Beheer B.V., Oudewater, The Netherlands.  
m  Medetomidine hydrochloride, Le Vet Beheer B.V.   
n  Amoxicillin clavulanate, GlaxoSmithKline, Middlesex, UK.   
o  Levothyroxine sodium, Eurovet Animal Health B.V.   
p  Amoxicillin clavulanate, Norbrook Laboratories Ltd.   
q  Tramadol hydrochloride, Bristol Laboratories, Bristol, UK.  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